BioBanking quarterly reports
31 December 2011
BioBanking Funds are invested within TCorp’s Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility; and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 31 December 2011 the total funds held within the BioBanking Trust Fund were $2,365,132.84 (includes funds in both T-Corp and Westpac).
For the quarter ending 31 December 2011 $17,844.65 was deposited into the fund. There was also a withdrawal of $38,272.52 from the fund to cover an anniversary management payment for one landowner.
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
For the quarter ending 31 December 2011 there was a net investment return of $38,231.27.
30 September 2011
BioBanking Funds are invested within TCorp’s Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 30 September 2011 the total funds held within the BioBanking Trust Fund were $2,350,461.45 (includes funds in both T-Corp and Westpac).
For the quarter ending 30 September 2011 $772,668.60 was deposited into the fund.
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility – returned 1.22%
Medium Term Growth Facility – returned (1.71%)
Long Term Growth Facility – returned (7.11%)
For the quarter ending 30 September 2011 there was a net investment loss of $51,729.97.
30 June 2011
BioBanking Funds are invested within TCorp’s Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 30 June 2011 the total funds held within the BioBanking Trust Fund were $1,761,372.12 (includes funds in both T-Corp and Westpac).
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility – returned 1.31%
Medium Term Growth Facility – returned 0.36%
Long Term Growth Facility – returned (1.64%)
For the quarter ending 30 June 2011 there was a net investment loss of $962.11.
31March 2011
BioBanking Funds are invested within TCorp’s Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 31 March 2011 the total funds held within the BioBanking Trust Fund were $1,432,267.92 (includes funds in both T-Corp and Westpac).
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility – returned 1.35%
Medium Term Growth Facility – returned 2.25%
Long Term Growth Facility – returned 3.18%
For the quarter ending 31 March 2011 there was a net investment return of $20,827.43.
For the quarter ending 31 March 2011 $888,403.00 was deposited into the fund.
31 December 2010
BioBanking Funds are invested within TCorp's Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 31 December 2010 the total funds held within the BioBanking Trust Fund were $523,037.49 (includes funds in both T-Corp and Westpac).
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility – returned 1.34%
Medium Term Growth Facility – returned 1.65%
Long Term Growth Facility – returned 2.62%
For the quarter ending 31 December 2010 there was a net investment return of $9,973.14.
30 September 2010
BioBanking Funds are invested within TCorp's Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 30 September 2010 the total funds held within the BioBanking Trust Fund were $513,064.35 (includes funds in both T-Corp and Westpac).
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility - returned 1.26%
Medium Term Growth Facility - returned 2.71%
Long Term Growth Facility - returned 4.19%
For the quarter ending 30 September 2010 there was a net investment return of $14,184.08.
BioBanking Funds are invested within TCorp's Hour-Glass Investment Facilities in three investment options: Cash Facility; Medium Term Growth Facility: and Long Term Growth Facility. An operating account is also held with Westpac to receive deposits and make payments.
As at 30 June 2010 the total funds held within the BioBanking Trust Fund were $498,880.27 (includes funds in both T-Corp and Westpac).
Investment performance for the quarter in each of the Hour-Glass Facilities was as follows:
Cash Facility - returned 1.17%
Medium Term Growth Facility - returned 0.93%
Long Term Growth Facility - returned 4.83%
For the quarter ending 30 June 2010 there was a net investment loss of $2,748.73.
No funds have been received into the BioBanking Trust Fund as at 31 March 2010.
No funds have been received into the BioBanking Trust Fund as at 31 December 2009.
No funds have been received into the BioBanking Trust Fund as at 30 September 2009.
No funds have been received into the BioBanking Trust Fund as at 30 June 2009.
No funds have been received into the BioBanking Trust Fund as at 31 March 2009.
No funds have been received into the BioBanking Trust Fund as at 31 December 2008.
No funds have been received into the Biobanking Trust Fund as at 30 September 2008.
Page last updated: 05 April 2012
